EUVIMEDEUVIMED entdecken
Crossref

Cardiovascular risk in long-term survivors of breast, prostate, colon, and rectal cancer

Sarah J Westvold iD, Jessica B Long, Jane Fan iD, Madhav Kc iD, Terry Hyslop iD, Kerry Conlin iD, Sofia Jacobson, Andrea Silber iD, Shi-Yi Wang iD, Michael S Leapman iD, Ira Leeds iD, Lisa Spees iD und 4 weitere

JNCI: Journal of the National Cancer Institute · 01.01.2026 · 118 (1) · 130-140

DOI: 10.1093/jnci/djaf243 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, online erschienen am 09.10.2025. Verfasst von Sarah J Westvold und 15 weiteren Autor:innen. Beteiligte Einrichtung: Yale Cancer Outcomes, Public Policy, and Effectiveness Research Center, New Haven, CT, United States. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Cancer Survivors, Breast Neoplasms, Rectal Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: American Cancer Society, NCCN Foundation, Pfizer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cardiovascular disease (CVD) is the leading cause of noncancer mortality in long-term cancer survivors. Population-level assessment of cancer-related exposures is limited with respect to long-term cardiovascular risk in older survivors who have additional aging-related risks.

Methods

This was a Surveillance, Epidemiology, and End Results–Medicare retrospective cohort study of long-term (5-year) survivors of breast, prostate, colon, and rectal cancers who were aged 66 years and older, diagnosed from 2003 to 2012, and received definitive treatment. The primary endpoint was late CVD, defined as myocardial infarction, stroke, congestive heart failure, or cardiomyopathy on an inpatient administrative claim or as Surveillance, Epidemiology, and End Results cause of death occurring 5-15 years postdiagnosis. Restricted mean survival time regression was used to assess predictors of shorter average time without CVD and develop a prediction rule for risk stratification. Survivors were assigned a risk score and stratified into tertiles.

Results

Included were 95 100 survivors with a mean age of 74 (6) years at diagnosis. Late CVD occurred in 23.2% of survivors. Older age, comorbidities, and prior CVD were associated with a shorter time without CVD. In contrast, cancer-related factors were not associated, except for stage III breast cancer, and radiation plus androgen deprivation therapy for prostate cancer. Across all cohorts, the high-risk strata had a three- to fourfold higher risk of CVD compared with the low-risk strata.

Conclusions

In this cohort of older, long-term cancer survivors, cancer-related exposures were not independently associated with onset of CVD 5-15 years after diagnosis but may still contribute to latent cardiovascular risk. Given the limited impact of cancer-specific factors, cancer-agnostic risk prediction may be adequate to predict individual cardiovascular risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesCancer SurvivorsBreast NeoplasmsRectal NeoplasmsProstatic NeoplasmsColonic NeoplasmsHumansMaleAgedFemaleRetrospective StudiesSEER ProgramAged, 80 and overUnited StatesRisk Factors

Autor:innen und Institutionen

  • Yale Cancer Outcomes, Public Policy, and Effectiveness Research Center, New Haven, CT, United States.
  • Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, United States.
  • Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, United States.
  • Yale College, New Haven, CT, United States.
  • Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, United States.
  • Department of Urology, Yale University School of Medicine, New Haven, CT, United States.

ORCID-Profile: Sarah J Westvold, Jane Fan, Madhav Kc, Terry Hyslop, Kerry Conlin, Andrea Silber, Shi-Yi Wang, Michael S Leapman, Ira Leeds, Lisa Spees, Stephanie B Wheeler, Cary P Gross, Kevin Oeffinger, Michaela A Dinan

Förderung

  • American Cancer Society
  • NCCN Foundation
  • Pfizer

Zitieren

APA

Westvold, S. J., Long, J. B., Fan, J., Kc, M., Hyslop, T., Conlin, K., Jacobson, S., Silber, A., Wang, S. Y., Leapman, M. S., Leeds, I., Spees, L., Wheeler, S. B., Gross, C. P., Oeffinger, K., & Dinan, M. A. (2026). Cardiovascular risk in long-term survivors of breast, prostate, colon, and rectal cancer. JNCI: Journal of the National Cancer Institute, 118(1), 130-140. https://doi.org/10.1093/jnci/djaf243

Vancouver

Westvold SJ, Long JB, Fan J, Kc M, Hyslop T, Conlin K, et al. Cardiovascular risk in long-term survivors of breast, prostate, colon, and rectal cancer. JNCI: Journal of the National Cancer Institute. 2026;118(1):130-140. doi:10.1093/jnci/djaf243

BibTeX
@article{Westvold2026,
  author = {Westvold, Sarah J and Long, Jessica B and Fan, Jane and Kc, Madhav and Hyslop, Terry and Conlin, Kerry and Jacobson, Sofia and Silber, Andrea and Wang, Shi-Yi and Leapman, Michael S and Leeds, Ira and Spees, Lisa and Wheeler, Stephanie B and Gross, Cary P and Oeffinger, Kevin and Dinan, Michaela A},
  title = {Cardiovascular risk in long-term survivors of breast, prostate, colon, and rectal cancer},
  journal = {JNCI: Journal of the National Cancer Institute},
  year = {2026},
  volume = {118},
  number = {1},
  pages = {130--140},
  doi = {10.1093/jnci/djaf243}
}
Kostenlos starten →